Skip to main content
Journal of the Endocrine Society logoLink to Journal of the Endocrine Society
. 2019 Apr 30;3(Suppl 1):OR21-4. doi: 10.1210/js.2019-OR21-4

OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia

Ellen Seely 1, Jennifer Stuart 1, Geraldine Skurnik 1, Andrea Roche 1, Eleni Tsigas 4, Garrett Fitzmaurice 3, Louise Wilkins-Haug 1, Sue Levkoff 2, Janet Rich-Edwards 1
PMCID: PMC6554792

Abstract

BACKGROUND: Preeclampsia is associated with a 2 to 3-fold increased risk for future maternal cardiovascular disease (CVD).To reduce CVD risk and overcome participation barriers, we tested an online intervention to promote a healthy lifestyle among women with recent preeclampsia. METHODS: We conducted a 9-month randomized controlled trial among 151 US women with preeclampsia within the prior 5 years. Preeclampsia history was validated by medical record review for new-onset hypertension (systolic blood pressure ≥140 and/or diastolic blood pressure ≥90 mm Hg) with proteinuria (≥ 300 mg/24hr, or urine protein/urine creatinine ratio ≥ 0.3 or urine dipstick ≥ 1+) after 20 weeks gestation. The intervention group received a patient-centered program, Heart Health 4 Moms (HH4M), created with input from preeclampsia survivors and the Preeclampsia Foundation. The program, available in English and Spanish, included online educational modules, a community forum, heart healthy resources (e.g., meal plans), and communication with a lifestyle coach including 6 scheduled phone calls. The control group received access to a website with links to CVD risk reduction websites accessible to the general public. Primary outcomes were self-efficacy for healthy eating and increasing physical activity; change in physical activity/inactivity; adherence to the Dietary Approaches to Stop Hypertension diet; and knowledge of and personal control over CVD risk. Secondary outcomes were weight and blood pressure. We used the Hochberg method to adjust the p value for multiple comparisons. RESULTS: Participants were, on average, 31 years of age, 1.3 years removed from their preeclampsia pregnancy, predominantly non-Hispanic white and resided in 41 US states. Retention rates were high (control 93%; intervention 91%). During the 9 months of follow-up, 69% of control participants and 99% of intervention participants visited the study website (p<0.00001). In the intervention arm, 84% of participants accessed at least one online educational module and 89% completed at least three scheduled calls with the coach. At the end of follow-up, intervention participants reported increased self-efficacy for healthy eating (p=0.03), greater knowledge of CVD risk factors (p=0.01), and less physical inactivity (p=0.0006) than individuals in the control arm. The groups did not differ in personal control over CVD risk, self-efficacy for physical activity, or reported physical activity levels. There were no differences in secondary outcomes between groups. CONCLUSIONS: The on-line HH4M program was used by women with recent preeclampsia across the US, improved their self-efficacy to achieve a healthy diet and their knowledge of CVD risk and reduced their physical inactivity. HH4M provides a model for an on-line, easily-accessible lifestyle program to reduce CVD risk in women with recent preeclampsia. (Funded by PCORI).


Articles from Journal of the Endocrine Society are provided here courtesy of The Endocrine Society

RESOURCES